DIALYSIS · CCN 332621
DaVita Haven Dialysis
NEW YORK, NY 10032
DialysisProfitDaVita
$3.1M
TOTAL REVENUE
-37.1%
OPERATING MARGIN
5 / 5
STAR RATING
10
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2025)
- Net patient revenue
- $3.1M
- Total costs
- $4.2M
- Operating income (rev − costs)
- −$1.1M
- Operating margin
- -37.1%
- Total charges
- $2.9M
- Total treatments
- 6,640
- Dialysis stations
- 24
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
10 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 0.53 | 36 | — |
Five Star Rating DFC_FIVE_STAR | 5 | — | — |
First Year Standardized Kidney Transplant Waitlist Ratio DFC_FYSWR | 2.42 | 40 | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 2 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 137.2 | 93 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 13.5 | 510 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 43.9 | 29 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 19.4 | 35 | — |
Standardized ED Visits Ratio DFC_SEDR | 0.69 | 33 | — |
Patient Transfusion Rate DFC_TRANSFUSION_RATE | 20.2 | 28 | — |